相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。NK cell-based cancer immunotherapy: from basic biology to clinical development
Sizhe Liu et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)
The role of natural killer cell in gastrointestinal cancer: killer or helper
Feixue Wang et al.
ONCOGENE (2021)
Theranostic combinatorial drug-loaded coated cubosomes for enhanced targeting and efficacy against cancer cells
Leilei Zhang et al.
CELL DEATH & DISEASE (2020)
NK Cells Augment Oncolytic Adenovirus Cytotoxicity in Ovarian Cancer
Elaine Y. L. Leung et al.
MOLECULAR THERAPY-ONCOLYTICS (2020)
Mesenchymal stem cells used as carrier cells of oncolytic adenovirus results in enhanced oncolytic virotherapy
Khaphetsi Joseph Mahasa et al.
SCIENTIFIC REPORTS (2020)
Modeling Oncolytic Viral Therapy, Immune Checkpoint Inhibition, and the Complex Dynamics of Innate and Adaptive Immunity in Glioblastoma Treatment
Kathleen M. Storey et al.
FRONTIERS IN PHYSIOLOGY (2020)
Unleashing Natural Killer Cells in the Tumor Microenvironment-The Next Generation of Immunotherapy?
Aviad Ben-Shmuel et al.
FRONTIERS IN IMMUNOLOGY (2020)
Combining Oncolytic Viruses With Cancer Immunotherapy: Establishing a New Generation of Cancer Treatment
Tao Shi et al.
FRONTIERS IN IMMUNOLOGY (2020)
Oncolytic Activity of Targeted Picornaviruses Formulated as Synthetic Infectious RNA
Noura B. Elsedawy et al.
MOLECULAR THERAPY-ONCOLYTICS (2020)
Expanding the Spectrum of Adenoviral Vectors for Cancer Therapy
Jian Gao et al.
CANCERS (2020)
Effective Treatment of Glioblastoma Multiforme With Oncolytic Virotherapy: A Case-Series
Benjamin Gesundheit et al.
FRONTIERS IN ONCOLOGY (2020)
The two-faces of NK cells in oncolytic virotherapy
M. Marotel et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2020)
Oncolytic Viruses and the Immune System: The Dynamic Duo
Ana Lemos de Matos et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2020)
In Situ Therapeutic Cancer Vaccination with an Oncolytic Virus Expressing Membrane-Tethered IL-2
Weilin Liu et al.
MOLECULAR THERAPY-ONCOLYTICS (2020)
Oncolytic viral therapies and the delicate balance between virus-macrophage-tumour interactions: A mathematical approach
Nada Almuallem et al.
MATHEMATICAL BIOSCIENCES AND ENGINEERING (2020)
Enhancing network activation in natural killer cells: predictions from in silico modeling
Sahak Z. Makaryan et al.
INTEGRATIVE BIOLOGY (2020)
The prognostic role of NK cells and their ligands in squamous cell carcinoma of the head and neck: a systematic review and meta-analysis
Sangeeta K. Bisheshar et al.
ONCOIMMUNOLOGY (2020)
Oncolytic viruses: how lytic must they be for therapeutic efficacy?
Maria Eugenia Davola et al.
ONCOIMMUNOLOGY (2019)
In Vivo Imaging of Oncolytic Measles Virus Propagation with Single-Cell Resolution
Iris Kemler et al.
MOLECULAR THERAPY-ONCOLYTICS (2019)
Oncolytic virus immunotherapy induces immunogenic cell death and overcomes STING deficiency in melanoma
Praveen K. Bommareddy et al.
ONCOIMMUNOLOGY (2019)
Oncolytic Viruses: Priming Time for Cancer Immunotherapy
Luke Russell et al.
BIODRUGS (2019)
Mesenchymal Stem Cell-Mediated Delivery of an Oncolytic Adenovirus Enhances Antitumor Efficacy in Hepatocellular Carcinoma
A-Rum Yoon et al.
CANCER RESEARCH (2019)
Multifunctional Natural Killer Cell Engagers Targeting NKp46 Trigger Protective Tumor Immunity
Laurent Gauthier et al.
CELL (2019)
Optimizing oncolytic virotherapy in cancer treatment
Kevin Harrington et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Correlation Between Natural Killer Cell Activity and Treatment Effect in Patients with Disseminated Cancer
Torben Frostrup Hansen et al.
TRANSLATIONAL ONCOLOGY (2019)
Cancer Immunotherapy Based on Natural Killer Cells: Current Progress and New Opportunities
Weilei Hu et al.
FRONTIERS IN IMMUNOLOGY (2019)
The Oncolytic Virus dl922-947 Triggers Immunogenic Cell Death in Mesothelioma and Reduces Xenograft Growth
Sarah Di Somma et al.
FRONTIERS IN ONCOLOGY (2019)
Immunogenic Cell Death and Immunotherapy of Multiple Myeloma
Alfonso Serrano-del Valle et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2019)
Investigating Macrophages Plasticity Following Tumour-Immune Interactions During Oncolytic Therapies
R. Eftimie et al.
ACTA BIOTHEORETICA (2019)
Backward Hopf bifurcation in a mathematical model for oncolytic virotherapy with the infection delay and innate immune effects
Yuxiao Guo et al.
JOURNAL OF BIOLOGICAL DYNAMICS (2019)
Immune Conversion of Tumor Microenvironment by Oncolytic Viruses: The Protoparvovirus H-1PV Case Study
Antonio Marchini et al.
FRONTIERS IN IMMUNOLOGY (2019)
Oncolytic virotherapy for tumours following a Gompertz growth law
Adrianne L. Jenner et al.
JOURNAL OF THEORETICAL BIOLOGY (2019)
Natural Killer Cell Therapy: A New Treatment Paradigm for Solid Tumors
Sooyeon Oh et al.
CANCERS (2019)
Biological treatment of pediatric sarcomas by combined virotherapy and NK cell therapy
Chihab Klose et al.
BMC CANCER (2019)
Oncolytic reovirus as a combined antiviral and anti-tumour agent for the treatment of liver cancer
Adel Samson et al.
GUT (2018)
Efficacy of combining ING4 and TRAIL genes in cancer-targeting gene virotherapy strategy: first evidence in preclinical hepatocellular carcinoma
A. Galal El-Shemi et al.
GENE THERAPY (2018)
Tumor immunotherapy: New aspects of natural killer cells
Yangxi Li et al.
CHINESE JOURNAL OF CANCER RESEARCH (2018)
Strategies to Enhance NK Cell Function for the Treatment of Tumors and Infections
Jacquelyn Freund-Brown et al.
CRITICAL REVIEWS IN IMMUNOLOGY (2018)
Critical Interactions between Immunogenic Cancer Cell Death, Oncolytic Viruses, and the Immune System Define the Rational Design of Combination Immunotherapies
Jacob P. van Vloten et al.
JOURNAL OF IMMUNOLOGY (2018)
Oncolytic Virus Combination Therapy: Killing One Bird with Two Stones
Nikolas Tim Martin et al.
MOLECULAR THERAPY (2018)
Combination therapy for cancer with oncolytic virus and checkpoint inhibitor: A mathematical model
Avner Friedman et al.
PLOS ONE (2018)
Complex role of NK cells in regulation of oncolytic virus-bortezomib therapy
Yangjin Kim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Antitumor Benefits of Antiviral Immunity: An Underappreciated Aspect of Oncolytic Virotherapies
Shashi Gujar et al.
TRENDS IN IMMUNOLOGY (2018)
In Vivo Estimation of Oncolytic Virus Populations within Tumors
Mi-Yeon Jung et al.
CANCER RESEARCH (2018)
The Current Status and Future Prospects of Oncolytic Viruses in Clinical Trials against Melanoma, Glioma, Pancreatic, and Breast Cancers
Ibrahim Ragab Eissa et al.
CANCERS (2018)
Translating the anti-myeloma activity of Natural Killer cells into clinical application
Cinzia Fionda et al.
CANCER TREATMENT REVIEWS (2018)
The Efficacy of Oncolytic Adenovirus Is Mediated by T-cell Responses against Virus and Tumor in Syrian Hamster Model
Xiaozhu Li et al.
CLINICAL CANCER RESEARCH (2017)
Modelling and investigation of the CD4+ T cells - Macrophages paradox in melanoma immunotherapies
Raluca Eftimie et al.
JOURNAL OF THEORETICAL BIOLOGY (2017)
Oncolytic potency and reduced virus tumor-specificity in oncolytic virotherapy. A mathematical modelling approach
Khaphetsi Joseph Mahasa et al.
PLOS ONE (2017)
Evaluating optimal therapy robustness by virtual expansion of a sample population, with a case study in cancer immunotherapy
Syndi Barish et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Complex Dynamics of Virus Spread from Low Infection Multiplicities: Implications for the Spread of Oncolytic Viruses
Ignacio A. Rodriguez-Brenes et al.
PLOS COMPUTATIONAL BIOLOGY (2017)
NK-Cell Recruitment Is Necessary for Eradication of Peritoneal Carcinomatosis with an IL12-Expressing Maraba Virus Cellular Vaccine
Almohanad A. Alkayyal et al.
CANCER IMMUNOLOGY RESEARCH (2017)
Immune System, Friend or Foe of Oncolytic Virotherapy?
Anna C. Finley et al.
FRONTIERS IN ONCOLOGY (2017)
The Role of the Innate Immune System in Oncolytic Virotherapy
Tuan Anh Phan et al.
COMPUTATIONAL AND MATHEMATICAL METHODS IN MEDICINE (2017)
Bortezomib Treatment Sensitizes Oncolytic HSV-1-Treated Tumors to NK Cell Immunotherapy
Ji Young Yoo et al.
CLINICAL CANCER RESEARCH (2016)
Immunosurveillance and immunotherapy of tumors by innate immune cells
Alexandre Iannello et al.
CURRENT OPINION IN IMMUNOLOGY (2016)
From concept to clinic: Mathematically informed immunotherapy
Rachel Walker et al.
CURRENT PROBLEMS IN CANCER (2016)
Combined therapy with oncolytic adenoviruses encoding TRAIL and IL-12 genes markedly suppressed human hepatocellular carcinoma both in vitro and in an orthotopic transplanted mouse model
Adel Galal El-Shemi et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2016)
Mathematical model of tumor-immune surveillance
Khaphetsi Joseph Mahasa et al.
JOURNAL OF THEORETICAL BIOLOGY (2016)
Overcoming Barriers in Oncolytic Virotherapy with HDAC Inhibitors and Immune Checkpoint Blockade
Antonio Marchini et al.
VIRUSES-BASEL (2016)
A combinational therapy of EGFR-CAR NK cells and oncolytic herpes simplex virus 1 for breast cancer brain metastases
Xilin Chen et al.
ONCOTARGET (2016)
Roles of natural killer cells in antiviral immunity
Stephen N. Waggoner et al.
CURRENT OPINION IN VIROLOGY (2016)
Natural killer cell memory in infection, inflammation and cancer
Adelheid Cerwenka et al.
NATURE REVIEWS IMMUNOLOGY (2016)
Effects of CCN1 and Macrophage Content on Glioma Virotherapy: A Mathematical Model
Karly Jacobsen et al.
BULLETIN OF MATHEMATICAL BIOLOGY (2015)
Polymeric oncolytic adenovirus for cancer gene therapy
Joung-Woo Choi et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Memory versus effector immune responses in oncolytic virotherapies
Cicely Macnamara et al.
JOURNAL OF THEORETICAL BIOLOGY (2015)
Cytokine-Mediated Activation of NK Cells during Viral Infection
Bailey E. Freeman et al.
JOURNAL OF VIROLOGY (2015)
QUANTITATIVE IMPACT OF IMMUNOMODULATION VERSUS ONCOLYSIS WITH CYTOKINE-EXPRESSING VIRUS THERAPEUTICS
Peter S. Kim et al.
MATHEMATICAL BIOSCIENCES AND ENGINEERING (2015)
Oncolytic Virotherapy and Immunogenic Cancer Cell Death: Sharpening the Sword for Improved Cancer Treatment Strategies
Samuel T. Workenhe et al.
MOLECULAR THERAPY (2014)
Immunogenic HSV-mediated Oncolysis Shapes the Antitumor Immune Response and Contributes to Therapeutic Efficacy
Samuel T. Workenhe et al.
MOLECULAR THERAPY (2014)
Maraba MG1 Virus Enhances Natural Killer Cell Function via Conventional Dendritic Cells to Reduce Postoperative Metastatic Disease
Jiqing Zhang et al.
MOLECULAR THERAPY (2014)
Immunosurveillance of senescent cancer cells by natural killer cells
Alexandre Iannello et al.
ONCOIMMUNOLOGY (2014)
Chemotherapy and oncoyic virotherapy: advanced tactics in the war against cancer
Andrew Nguyen et al.
FRONTIERS IN ONCOLOGY (2014)
Oncolytic immunotherapy: dying the right way is a key to eliciting potent antitumor immunity
Zong Sheng Guo et al.
FRONTIERS IN ONCOLOGY (2014)
Tumor Restrictions to Oncolytic Virus
Markus Vaehae-Koskela et al.
BIOMEDICINES (2014)
Control of Human Viral Infections by Natural Killer Cells
Stephanie Jost et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 31 (2013)
Measles virus causes immunogenic cell death in human melanoma
O. G. Donnelly et al.
GENE THERAPY (2013)
Myxoma Virus Infection Promotes NK Lysis of Malignant Gliomas In Vitro and In Vivo
Henry Ogbomo et al.
PLOS ONE (2013)
Mathematical Model for Radial Expansion and Conflation of Intratumoral Infectious Centers Predicts Curative Oncolytic Virotherapy Parameters
Kent Bailey et al.
PLOS ONE (2013)
COMPUTATIONAL MODELING APPROACHES TO STUDYING THE DYNAMICS OF ONCOLYTIC VIRUSES
Dominik Wodarz
MATHEMATICAL BIOSCIENCES AND ENGINEERING (2013)
Evolution of oncolytic adenovirus for cancer treatment
Joung-Woo Choi et al.
ADVANCED DRUG DELIVERY REVIEWS (2012)
Complete eradication of hepatomas using an oncolytic adenovirus containing AFP promoter controlling E1A and an E1B deletion to drive IL-24 expression
K-J Zhang et al.
CANCER GENE THERAPY (2012)
Coxsackievirus B3 Is an Oncolytic Virus with Immunostimulatory Properties That Is Active against Lung Adenocarcinoma
Shohei Miyamoto et al.
CANCER RESEARCH (2012)
Hematological Malignancies Escape from NK Cell Innate Immune Surveillance: Mechanisms and Therapeutic Implications
Laure Farnault et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2012)
Strengthening of antitumor immune memory and prevention of thymic atrophy mediated by adenovirus expressing IL-12 and GM-CSF
K-J Choi et al.
GENE THERAPY (2012)
Harnessing Oncolytic Virus-mediated Antitumor Immunity in an Infected Cell Vaccine
Chantal G. Lemay et al.
MOLECULAR THERAPY (2012)
Oncolytic virotherapy
Stephen J. Russell et al.
NATURE BIOTECHNOLOGY (2012)
NK cells impede glioblastoma virotherapy through NKp30 and NKp46 natural cytotoxicity receptors
Christopher A. Alvarez-Breckenridge et al.
NATURE MEDICINE (2012)
Into the Eye of the Cytokine Storm
Jennifer R. Tisoncik et al.
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2012)
Combined Therapy with Cytokine-Induced Killer Cells and Oncolytic Adenovirus Expressing IL-12 Induce Enhanced Antitumor Activity in Liver Tumor Model
Zhi Yang et al.
PLOS ONE (2012)
Complex Spatial Dynamics of Oncolytic Viruses In Vitro: Mathematical and Experimental Approaches
Dominik Wodarz et al.
PLOS COMPUTATIONAL BIOLOGY (2012)
Understanding natural killer cell regulation by mathematical approaches
Carsten Watzl et al.
FRONTIERS IN IMMUNOLOGY (2012)
Targeting natural killer cells and natural killer T cells in cancer
Eric Vivier et al.
NATURE REVIEWS IMMUNOLOGY (2012)
Deciphering the Multifaceted Relationship between Oncolytic Viruses and Natural Killer Cells
Christopher A. Alvarez-Breckenridge et al.
ADVANCES IN VIROLOGY (2012)
Immune Recruitment and Therapeutic Synergy: Keys to Optimizing Oncolytic Viral Therapy?
Jay D. Naik et al.
CLINICAL CANCER RESEARCH (2011)
Sensitivity analysis approaches applied to systems biology models
Z. Zi
IET SYSTEMS BIOLOGY (2011)
Viral genome DNA/lipoplexes elicit in situ oncolytic viral replication and potent antitumor efficacy via systemic delivery
Oh-Joon Kwon et al.
JOURNAL OF CONTROLLED RELEASE (2011)
Oncolytic Virus-initiated Protective Immunity Against Prostate Cancer
Shashi A. Gujar et al.
MOLECULAR THERAPY (2011)
Adaptive Antiviral Immunity Is a Determinant of the Therapeutic Success of Oncolytic Virotherapy
Paul T. Sobol et al.
MOLECULAR THERAPY (2011)
Mutations in the Stalk Region of the Measles Virus Hemagglutinin Inhibit Syncytium Formation but Not Virus Entry
Matthew K. Ennis et al.
JOURNAL OF VIROLOGY (2010)
Host Lymphodepletion Enhances the Therapeutic Activity of an Oncolytic Vaccinia Virus Expressing 4-1BB Ligand
Hong Sung Kim et al.
CANCER RESEARCH (2009)
A Multiscale Mathematical Model for Oncolytic Virotherapy
Leticia R. Paiva et al.
CANCER RESEARCH (2009)
The Case of Oncolytic Viruses Versus the Immune System: Waiting on the Judgment of Solomon
Robin J. Prestwich et al.
HUMAN GENE THERAPY (2009)
A change of strategy in the war on cancer
Robert A. Gatenby
NATURE (2009)
Oncolytic viruses: a novel form of immunotherapy
Robin J. Prestwich et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2008)
Modeling of cancer virotherapy with recombinant measles viruses
Zeljko Bajzer et al.
JOURNAL OF THEORETICAL BIOLOGY (2008)
A methodology for performing global uncertainty and sensitivity analysis in systems biology
Simeone Marino et al.
JOURNAL OF THEORETICAL BIOLOGY (2008)
Oncolytic viruses in cancer therapy
Markus J. V. Vaha-Koskela et al.
CANCER LETTERS (2007)
Clinically significant prostate cancer local recurrence after radiation therapy occurs at the site of primary tumor: magnetic resonance imaging and step-section pathology evidence
Darko Pucar et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2007)
Targeted inflammation during oncolytic virus therapy severely compromises tumor blood flow
Caroline J. Breitbach et al.
MOLECULAR THERAPY (2007)
Dynamics of killer T cell inflation in viral infections
Dominik Wodarz et al.
JOURNAL OF THE ROYAL SOCIETY INTERFACE (2007)
Oncolytic immunovirotherapy for melanoma using vesicular stomatitis virus
Rosa Maria Diaz et al.
CANCER RESEARCH (2007)
Model-driven approaches for in vitro combination therapy using ONYX-015 replicating oncolytic adenovirus
Ryan Zurakowski et al.
JOURNAL OF THEORETICAL BIOLOGY (2007)
Enhanced antitumor effect of oncolytic adenovirus expressing interleukin-12 and B7-1 in an immunocompetent murine model
Young-Sook Lee et al.
CLINICAL CANCER RESEARCH (2006)
Mixed immunotherapy and chemotherapy of tumors: modeling, applications and biological interpretations
LG de Pillis et al.
JOURNAL OF THEORETICAL BIOLOGY (2006)
Glioma virotherapy: Effects of innate immune suppression and increased viral replication capacity
A Friedman et al.
CANCER RESEARCH (2006)
Mathematical modeling of cancer radiovirotherapy
D Dingli et al.
MATHEMATICAL BIOSCIENCES (2006)
Oncolytic viral therapies - the clinical experience
M Aghi et al.
ONCOGENE (2005)
Replication-selective oncolytic viruses in the treatment of cancer
B Everts et al.
CANCER GENE THERAPY (2005)
Ad-mTERT-Δ19, a conditional replication-competent adenovirus driven by the human telomerase promoter, selectively replicates in and elicits cytopathic effect in a cancer cell-specific manner
E Kim et al.
HUMAN GENE THERAPY (2003)
Interaction of heat shock protein 70 peptide with NK cells involves the NK receptor CD94
C Gross et al.
BIOLOGICAL CHEMISTRY (2003)
Reproduction numbers and sub-threshold endemic equilibria for compartmental models of disease transmission
P van den Driessche et al.
MATHEMATICAL BIOSCIENCES (2002)
Hypoxia - A key regulatory factor in tumour growth
AL Harris
NATURE REVIEWS CANCER (2002)
分享论文
